John D. McCallion, Executive Vice President and Chief Financial Officer of MetLife, Inc., filed a Form 4 on November 20, 2026, disclosing the exercise of employee stock options and a same-day sale of 6,533 shares of common stock on November 18, 2026.

Key Highlights

  • Option exercise: McCallion exercised 6,533 employee stock options at an exercise price of $46.85 per share on November 18, 2026.
  • Shares sold: 6,533 shares of MetLife common stock were disposed of at a weighted average price of $99.8451 per share in multiple open market transactions.
  • Sale price range: Individual transactions occurred at prices between $99.56 and $100.205, inclusive.
  • Remaining holdings: Following the transactions, McCallion directly beneficially owned 269,137 shares of MetLife common stock.
  • Options extinguished: The exercised options, which had an expiration date of February 27, 2027, now show zero derivative securities remaining for that grant.
  • Option vesting history: According to the filing, the options became exercisable in three substantially equal installments on February 28, 2018, 2019, and 2020.

McCallion's Option Exercise and Share Sale at MetLife

According to the Form 4 filed with the SEC, John D. McCallion, EVP and Chief Financial Officer of MetLife, Inc. (NYSE:MET), carried out a two-step transaction on November 18, 2026. First, he exercised 6,533 employee stock options at an exercise price of $46.85 per share, a transaction coded "M" in the filing, bringing his directly held common stock position to 275,670 shares following that step.

In a simultaneous transaction coded "S," McCallion disposed of the same 6,533 shares at a weighted average price of $99.8451. The filing noted that shares were sold at prices ranging from $99.56 to $100.205, inclusive, across multiple open market transactions. The filing states that McCallion "undertakes to provide to the staff of the SEC, MetLife, Inc., or a security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price." After both transactions, his directly held beneficial ownership stood at 269,137 shares of common stock.

The options exercised were part of a grant with a conversion price of $46.85, with an expiration date of February 27, 2027. The filing disclosed that these options became exercisable in three substantially equal installments on February 28, 2018, 2019, and 2020. Following the exercise, the reporting person holds zero remaining derivative securities under that grant. The Form 4 was signed by Taylor McInerney Jansen as attorney-in-fact on November 20, 2026.

What Was Disclosed

MetLife CFO John D. McCallion disclosed the exercise of 6,533 stock options at $46.85 and the same-day open market sale of 6,533 shares at a weighted average of $99.8451, leaving him with direct beneficial ownership of 269,137 MetLife common shares.